The Research Coordinator will work full-time on an NIH-funded study that will enroll drug-resistant tuberculosis (TB) patients at a study site located in East London, South Africa. Patients will be screened by local, South African study staff within 2 weeks of the patient initiating a TB treatment regimen containing linezolid. After consent, participants will be randomized 1:1 to either receive standard of care treatment, or therapeutic dose monitoring. Participants will complete up to 8 study visits over 6 months of TB treatment; during these visits, clinical data will be collected through interviews and from medical record abstraction, and blood and sputum specimens will be collected for study-related testing. The Research Coordinator will establish a hybrid work schedule with the PI, working in the Einstein DGIM office at least 2-3 days per week when not traveling. The Research Coordinator will also visit the South African study site 3-4 times per year during 1-2 week trips.
Responsibilities:
Experience and Educational Background:
Skills and Competencies
Software Powered by iCIMS
www.icims.com